Children’s immune system could hold the key to preventing sepsis

  • Scientists have identified the key response that children use to control infections
  • Children are naturally more resistant to lots of infectious diseases
  • Sepsis affects more than 20 million people worldwide and is responsible for more deaths in the UK than bowel, breast and prostate cancer combined

Sepsis

Children’s immune systems could hold the key to preventing life-threatening infections and sepsis, a new study has revealed.

The ground-breaking research conducted by an international team of scientists at the University of Sheffield and Harvard T.H. Chan School of Public Health, has identified the key response that children use to control infections - making them resilient to many severe infections and sepsis.

Sepsis, also known as blood poisoning, is the reaction to an infection which causes the body to attack its own organs and tissue.

It affects more than 20 million people worldwide and is responsible for more deaths in the UK than bowel, breast and prostate cancer combined. It is often referred to as the hidden killer as symptoms initially present themselves as flu, gastroenteritis or a chest infection.

The new study, which is the first of its kind, has helped scientists identify key differences in cell-pathway activity in the blood of septic adults and children. Establishing the pathways that help prevent sepsis is a powerful new way to discover drugs for intervention against sepsis and provides direct insight into potential cures for the disease.

Winston Hide, Professor of Computational Biology at the University of Sheffield’s Institute of Translational Neuroscience (SITraN), is an author of the pioneering study published in the journal Molecular Systems Biology.

“Children are naturally more resistant to lots of infectious diseases,” said Professor Hide.

“During outbreaks like Spanish flu and Ebola we know that children survived much better than adults. By analysing the blood profiles of infected children and comparing them to adults with sepsis we were able to identify children whose natural resilience helped them to ward off infection.

“By using the lessons we have learnt from the immune systems of children, scientists can now unlock how to control the disease and prevent it from occurring as opposed to trying to fight the disease once it has manifested itself.”

The findings of the study are now being used to design drugs for research into prevention of other pathological diseases including Alzheimer’s.

View the full paper

Additional Information

The University of Sheffield

With almost 29,000 of the brightest students from over 140 countries, learning alongside over 1,200 of the best academics from across the globe, the University of Sheffield is one of the world’s leading universities.

A member of the UK’s prestigious Russell Group of leading research-led institutions, Sheffield offers world-class teaching and research excellence across a wide range of disciplines.

Unified by the power of discovery and understanding, staff and students at the university are committed to finding new ways to transform the world we live in.

Sheffield is the only university to feature in The Sunday Times 100 Best Not-For-Profit Organisations to Work For 2018 and for the last eight years has been ranked in the top five UK universities for Student Satisfaction by Times Higher Education.

​​Sheffield has six Nobel Prize winners among former staff and students and its alumni go on to hold positions of great responsibility and influence all over the world, making significant contributions in their chosen fields.
Global research partners and clients include Boeing, Rolls-Royce, Unilever, AstraZeneca, Glaxo SmithKline, Siemens and Airbus, as well as many UK and overseas government agencies and charitable foundations.

Contact

Amy Huxtable
Media Relations Officer
University of Sheffield
0114 222 9859
a.l.huxtable@sheffield.ac.uk